Sergio Giralt, MD
Memorial Sloan Kettering Cancer Center · Memorial Sloan Kettering Cancer Centre, New York City, United States · M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sergio Giralt, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05032820 · Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple MyelomaMedical College of Wisconsin · completed · Multiple Myeloma · principal investigator
- Ph1NCT04918511 · A Study of OPD5 Followed by Autologous Stem Cell Transplant for Patients With Relapsed Refractory Multiple MyelomaOncopeptides AB · withdrawn · Relapse Multiple Myeloma, Multiple Myeloma · principal investigator
- N/ANCT03276481 · Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell TransplantationMemorial Sloan Kettering Cancer Center · completed · Multiple Myeloma · principal investigator
- Ph2NCT02570542 · Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)Memorial Sloan Kettering Cancer Center · active not recruiting · Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL) · principal investigator
- Ph1/Ph2NCT01866293 · Cabozantinib (XL184) in Patients With Relapsed or Refractory MyelomaMemorial Sloan Kettering Cancer Center · completed · Relapsed or Refractory Multiple Myeloma · principal investigator
- Ph1NCT01758328 · Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple MyelomaMemorial Sloan Kettering Cancer Center · completed · Multiple Myeloma · principal investigator
- Ph2NCT01745588 · Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple MyelomaMemorial Sloan Kettering Cancer Center · completed · Multiple Myeloma · principal investigator
- Ph2NCT01596257 · Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell TransplantationMemorial Sloan Kettering Cancer Center · completed · Leukemia · principal investigator
- N/ANCT01324427 · Telemedicine Evaluation for Stem Cell Transplant PatientsMemorial Sloan Kettering Cancer Center · completed · Stem Cell Transplant Patients · principal investigator
- Ph2NCT01131169 · Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte InfusionsMemorial Sloan Kettering Cancer Center · completed · Multiple Myeloma · principal investigator
- Ph2NCT00002833 · Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaM.D. Anderson Cancer Center · completed · Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes · study chair
- Ph1/Ph2NCT00002831 · Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute LeukemiaM.D. Anderson Cancer Center · completed · Leukemia · study chair
- Ph1/Ph2NCT00002832 · Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaM.D. Anderson Cancer Center · completed · Leukemia, Myelodysplastic Syndromes · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Blood & Marrow Transplant Clinical Trials Network Data Coordinating CenterU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Mary Maresca Horowitz · fiscal years 2014 to 2016Named on NCT05032820
- A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy ResearchU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · fiscal years 2014 to 2026Named on NCT05032820
- Experimental Medicine ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FUNDA MERIC-BERNSTAM · fiscal years 2013 to 2026
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.